Can a diabetes drug protect transplanted kidneys from stress?
NCT ID NCT04918407
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 36 times
Summary
This study looked at whether adding empagliflozin to insulin can reduce oxidative stress in people with type 2 diabetes who have had a kidney transplant. Forty patients were split into two groups: one received empagliflozin plus insulin, the other insulin alone. After 90 days, researchers measured various markers of oxidative stress in the blood to see if empagliflozin made a difference.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT; COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Labbafinezhd Hospital
Tehran, 166663423, Iran
-
SBMU
Tehran, 1666664321, Iran
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.